Valuation: Novonesis A/S

Market Cap 206B 30.87B 27.58B 25.7B 23.3B 43.86B 2,930B 44.2B 308B 121B 1,524B 116B 113B 4,890B P/E 2026 *
37.4x
P/E 2027 * 32.3x
Enterprise Value 227B 33.94B 30.32B 28.26B 25.62B 48.21B 3,221B 48.59B 339B 133B 1,675B 127B 125B 5,376B EV / Sales 2026 *
6.79x
EV / Sales 2027 * 6.26x
Free-Float
74.08%
Yield 2026 *
1.65%
Yield 2027 * 1.84%
1 day+0.84%
1 week+2.97%
Current month+5.91%
1 month+3.47%
3 months+4.84%
6 months+15.58%
Current year+8.95%
1 week 426.8
Extreme 426.8
446.9
1 month 408.1
Extreme 408.1
448.1
Current year 336.8
Extreme 336.8
465
1 year 336.8
Extreme 336.8
465
3 years 274.6
Extreme 274.6
489.4
5 years 274.6
Extreme 274.6
545.8
10 years 220.7
Extreme 220.7
545.8
Date Insider Type Main position Quantity % Market Cap. Importance
11/21/25 Buy

Director

2,500 0.0006%
11/21/25 Buy

Director

2,500 0.0006%
11/7/25 Buy

Head of Human Resources

380 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.82%+2.97%+11.33%+54.00% 30.87B
+0.33%+1.72%+5.71%+73.52% 80.08B
+0.17%+11.79%+13.05%+31.31% 42.32B
+1.95%+3.22%+4.09%-23.68% 34.01B
+1.90%+3.86%+10.64%+14.35% 32.48B
+0.94%+0.32%-2.38%+19.26% 25.72B
+0.43%+3.22%+54.87%+41.12% 24.28B
-0.66%-5.05%+44.94%+9.38% 17.95B
-0.17%-2.80%-43.14%-42.72% 17.49B
-0.33%+2.40%-0.47%+88.77% 15.28B
Average +0.52%+1.63%+9.86%+26.53% 32.05B
Weighted average by Cap. +0.59%+2.51%+9.86%+33.73%

Financials

2026 *2027 *
Net sales 33.38B 5B 4.46B 4.16B 3.77B 7.1B 474B 7.16B 49.86B 19.52B 247B 18.77B 18.36B 792B 35.92B 5.38B 4.8B 4.48B 4.06B 7.64B 511B 7.7B 53.65B 21B 266B 20.2B 19.76B 852B
Net income 5.42B 812M 726M 676M 613M 1.15B 77.1B 1.16B 8.1B 3.17B 40.1B 3.05B 2.98B 129B 6.36B 953M 851M 793M 719M 1.35B 90.44B 1.36B 9.5B 3.72B 47.03B 3.58B 3.5B 151B
Net Debt 20.49B 3.07B 2.74B 2.55B 2.32B 4.36B 291B 4.39B 30.6B 11.98B 151B 11.52B 11.27B 486B 18.76B 2.81B 2.51B 2.34B 2.12B 3.99B 267B 4.02B 28.02B 10.97B 139B 10.55B 10.32B 445B
Projected Income Statement - Annual - Novonesis A/S
Logo Novonesis A/S
Novonesis A/S is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - agriculture, bioenergy and animal feed industries (35.8%); - food industries (33%); - cleaning and household care products industries (19.3%); - human nutritional health industries (11.9%). Net sales are geographically distributed as follows: Denmark (1.1%), Europe/Middle East/Africa (34.6%), North America (32%), Asia/Pacific (18.7%), and Latin America (13.6%).
Employees
11,098
Date Price Change Volume
26-10-14 DKK 444.30 +0.41% 83,584
26-10-13 DKK 442.50 +1.56% 412,083
26-10-12 DKK 435.70 +0.14% 276,417
26-10-09 DKK 435.10 +1.68% 677,105
26-10-08 DKK 427.90 -0.83% 652,923
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Novonesis A/S
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
442.50DKK
Average target price
499.33DKK
Spread / Average Target
+12.84%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Novonesis A/S
  1. Stock Market
  2. Stocks
  3. NSIS B Stock